June 7 - 12, 2008
Macao SAR, China
Venetian Macao Resort Hotel

Programme

Monday, June 9

PARALLEL SESSIONS

08.30 – 10.00 Ballroom G - L

Parallel Session S1: Pathogen Reduction Inactivation
 

08.30 – 09.00
2A-S01-01 PATHOGEN REDUCTION: AN AMERICAN VIEW
H. Klein (NIH, Bethesda MD, USA)

09.00 – 09.30
2A-S01-02 EUROPEAN VIEW ABOUT PATHOGEN INACTIVATION IN LABILE BLOOD PRODUCTS
J.P. Cazenave (EFS-Alsace, Strasbourg, France)

09.30 – 09.45
2A-S01-03 A RANDOMIZED, CONTROLLED, 2-PERIOD CROSSOVER STUDY OF RECOVERY AND LIFESPAN OF RADIOLABELED AUTOLOGOUS 35-DAY-OLD RED BLOOD CELLS PREPARED WITH A MODIFIED S-303 TREATMENT FOR PATHOGEN INACTIVATION
J.A. Cancelas, L. Dumont, L. Herschel, J. Roger, N. Rugg, G. Garratty, P. Arndt, M. Propst, L. Laurence, D. Sundin, J. AuBuchon (University of Cincinnati, Cincinnati, USA)

09.45 – 10.00
2A-S01-04 EFFECTIVENESS OF A RIBOFLAVIN AND LIGHT BASED PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM TO ELIMINATE BABESIA MICROTI FROM APHERESIS PLATELETS AND PLASMA
L. Tonnetti, M. Proctor, H. Reddy, R. Goodrich, D. Leiby (American Red Cross, Rockville, USA)

08.30 – 10.00 Milan

Parallel Session S2: Quality Management of Blood Transfusion
 

08.30 – 09.00
2A-S02-01 LEVELS OF QUALITY MANAGEMENT OF BLOOD TRANSFUSION SERVICES
C. Seidl (RCBDS Institute of Transfusion Medicine, Frankfurt am Main, Germany)

09.00 – 09.30
2A-S02-02 QUALITY ASSURANCE TO MITIGATE RISK
E. Dax (National Serology Reference Laboratory, Fitzroy, Australia)

09.30 – 09.45
2A-S02-03 INTEGRATING ISO14001: 2004 INTO A QUALITY MANAGEMENT SYSTEM IN THE BLOOD TRANSFUSION SERVICE, HONG KONG
S. Cheng, C.K. Lin, C.K. Lee, W.C. Tsoi, E. Chua, J. Hong, S.H. Fan (Hong Kong Red Cross Blood Transfusion Service, Hong Kong, SAR China)

09.45 – 10.00
2A-S02-04 EVALUATION OF THE POTENTIAL RISKS AND BENEFITS OF U.S. BLOOD DONOR DEFERRAL SCENARIOS
S. Anderson, H. Yang, M. Walderhaug (U.S. Food & Drug Administration, Rockville, USA)

08.30 – 10.00 Napels

Parallel Session S3: Donor Recruitment and Retention
 

08.30 – 08.55
2A-S03-01 HCV INFECTION IN VOLUNTARY BLOOD DONORS AND INFLUENCE FOR DONOR MANAGEMENT IN CHONGQING AREA
S. Zhao (Chongqing Blood Center, Chongqing, China)

08.55 – 09.20
2A-S03-02 ISBT WP ON DONORS AND DONATION
D. de Coning (Safe Blood Consultant, Johannesburg, South Africa)

09.20 – 09.45
2A-S03-03 DONOR VIGILANCE
J. Jørgensen (Blood Transfusion Center, Aarhus, Denmark)

09.45 – 10.00
2A-S03-04 VIRTUAL DONOR CENTRE: USING SOCIAL SOFTWARE TO ATTRACT AND RECRUIT YOUNG BLOOD DONORS IN SCOTLAND
M.A. Hart, I.M. Franklin, M. Carter, L. Kidd (Scottish National Blood Transfusion Service, Edinburgh, United Kingdom)

08.30 – 10.00 Florence

Parallel Session S4: Components in Special Clinical Care
Chairs: J. Isbister, A. Maniatis
 

08.30 – 09.00
2A-S04-01 NEW THOUGHTS ON OLD RED CELLS
J. Hess (University of Maryland, Baltimore, USA)

09.00 – 09.30
2A-S04-02 HOW TO FURTHER DEVELOP THE EVIDENCE BASE FOR TRANSFUSION MEDICINE
M. Murphy, S. Brunskill, S. Stanworth, C. Doree, C. Hyde, D. Roberts (National Blood Service, Oxford, United Kingdom)

09.30 – 09.45
2A-S04-03 INACTIVATION OF LYMPHOCYTES IN BLOOD PRODUCTS USING RIBOFLAVIN PHOTOCHEMICAL TREATMENT WITH VISIBLE LIGHT
Z.L. Cui, Y.W. Huang, Q. Mo, X. Wang, K.C. Qian (Shanghai Blood Center, Shanghai, China)

09.45 – 10.00
2A-S04-04 EFFECT OF LEUCODEPLETION AND PERIOPERATIVE BLOOD TRANSFUSION ON SURVIVAL AND RECURRENCE IN GASTROINTESTINAL CANCER PATIENTS
J.A. van Hilten, M.M. Lange, L.M.G. van de Watering, C.J.H. van de Velde, A. Brand (Sanquin, Leiden, The Netherlands)

08.30 – 10.00 Sicily

Parallel Session S5: Haemoglobulinopathies
Chairs: C. Politis, D. Teo

08.30 – 09.00
2A-S05-01 THALESSEMIA
A. Eleftheriou (Thalassaemia International Federation, Athens, Greece)

09.00 – 09.30
2A-S05-02 SICKLE CELL
P. Hebbel (University of Minnesota, Minnesota, USA)

09.30 – 09.45
2A-S02-03 PATTERN OF ALLOIMUNIATION IN MULTI TRANSFUSED PATIENTS WITH MAEMOGLOBINOPATHIES IN SRI LANKA
K.A.D.D.P Kuruppu (National Blood Transfusion Service, Sri Lanka, Colombo, Sri Lanka)

09.45 – 10.00
2A-S02-03 TRANSFUSION COMPLICATIONS IN PATIENTS WITH THALASSEMIA MAJOR
D. Canatan, N. Balta, A. Azsancak, E. Kurtoglu (Antalya State Hospital, Antalya, Turkey)

10.00 – 10.30 Exhibition Area

COFFEE/TEA BREAK

10.30 – 12.00 Ballroom G - L

Plenary Session 1
Chairs: S. Takamoto, P. Hui

10.30 – 11.15
2B-PL01-01 BLOOD TRANSFUSION SERVICES/PRACTICE IN CHINA
W. Yu (Ministry of Health, Beijing, China)

11.15 – 12.00
2B-PL01-02 EMERGING TRANSFUSION TRANSMITTED INFECTIONS: SPECIES BARRIERS AND THE RISKS FOR TRANSFUSION MEDICINE
R.Y. Dodd (American Red Cross, Rockville, USA)

12.00 – 14.00

LUNCH BREAK AND SATELLITE SYMPOSIA

14.00 – 15.35 Ballroom G - L

Satellite Symposium

12.15 – 13.45 Milan

Satellite Symposium organised by Roche

SS3: Taking NAT to the Next Level

This symposium will cover some of the key considerations for the implementation of a NAT laboratory. These include the move towards automated systems for routine blood screening, preliminary results and work flow. Hot trends in blood screening, such as the implementation of pre-analytical instruments to streamline workflow and throughput will be presented. This symposium will offer an exciting glimpse into the laboratory of the future.

Speakers and presentations include:
Dr. Marie Dechaseaux, EFS, Dijon, France: NAT Laboratory Workflow
Dr. Viroje Chongkolwatana, Siriraj Hospital, Bangkok, Thailand: Comparison of NAT Automation
Dr. Isabelle Gonzalez, Centro de Hemoterapia y Hemodonación de Castilla y
León, Valladolid, Spain: Pre-analytics Options
Dr. Mike Strong, USA: The NAT Laboratory of the Future

Satellite Symposium

12.15 – 13.45 Milan

Fenwal, Innovative Solutions for the Future

SS4: Taking NAT to the Next Level

Chair: S. Rajadhyaksha

12.15 – 12.20
INTRODUCTION OF THE SYMPOSIUM AND MODERATION
S. Rajadhyaksha (Tata Memorial Hospital, Mumbai, India)

12.20 – 12.40
CURRENT CHALLENGES IN TRANSFUSION
S. Rajadhyaksha (Tata Memorial Hospital, Mumbai, India)

12.40 – 12.55
FENWAL, INNOVATIVE SOLUTIONS FOR THE FUTURE
 H. Uchida (Fenwal, Lake Zurich, USA)

12.55 – 13.10
HOW AUTOMATED RED BLOOD CELL COLLECTIONS CAN ADDRESS CURRENT BLOOD BANKING CHALLENGES. THE FRENCH EXPERIENCE
 O. Garraud (EFS Auvergne Loire, St Etienne, France)

13.10 – 13.25
EVALUATION OF PLATELET COLLECTION USING THE NEW AMICUS SOFTWARE
 W. Nussbaumer (University Clinic Blood Transfusion Center, Innsbruck, Austria)

13.25 – 13.40
QUESTIONS AND ANSWERS
 All speakers

13.40 – 13.45
CONCLUSION OF THE SYMPOSIUM
 S. Rajadhyaksha (Tata Memorial Hospital, Mumbai, India)

Satellite Symposium

12.15 – 13.45 Florence

Satellite Symposium organised by Macopharma

SS5: Pathogen Reduction: Implementation Strategies for Today and the Future

14.00 – 15.35 Ballroom G - L

Parallel Session S6: Vigilance Systems in Transfusion Medicine
Chairs: B. David, H. Okazaki

14:00 – 14:25
2C-S06-01 THE ISBT WORKING PARTY ON HAEMOVIGILANCE
P. Robillard (Québec Public Health Institute, Montreal, Canada)

14.25 – 15.50
2C-S06-02 BIOVIGILANCE INITIATIVES
M. Strong, J. AuBuchon, B. Whitaker, M. Kuehnert (Puget Sound Blood Center, Seattle, USA)

14.50 – 15.05
2C-S06-03 PREVENTABILITY OF SERIOUS TRANSFUSION REACTIONS
J.C. Wiersum-Osselton, A. Van Tilborgh, P. Zijlker-Jansen, M.R. Schipperus (TRIP Dutch National Hemovigilance Office, The Hague, The Netherlands)

15.05 – 15.20
2C-S06-04 ANALYSIS OF TRANSFUSION ERRORS AND NEAR-MISS EVENTS IN A BLOOD BANK SERVICE: RESULTS OF THE HEMOVIGILANCE PROGRAM
N. Carpio, F. Moscardó, I. Vaquero, F. Arriaga, J. Sanz, M.A. Sanz (Hospital Universitario La Fe, Valencia, Spain)

15.20 – 15.35
2C-S06-05 RESULTS FROM AN ONGOING HEMOVIGILANCE PROGRAM UTILIZING AN ELECTRONIC DATA CAPTURE SYSTEM TO CHARACTERIZE THE SAFETY PROFILE OF PLATELET TRANSFUSIONS PREPARED WITH PHOTOCHEMICAL TREATMENT (INTERCEPT™)
P. Rasongles, F. Knutson, O. Garraud, R. Tardivel, P. Schlenke, M. Lozano, L. Barbolla, M. Jacquet, L. Lin, L. Corash, D. Sundin (Etablissement Français du Sang-La Réunion, La Reunion, France)

14.00 – 15.30 Milan

Parallel Session S7: Leukocyte Depletion / Reduction
 

14.00 – 14.30
2C-S07-01 CLINICAL IMPACT OF LEUKOCYTE DEPLETION - WHAT IS EVIDENCE-BASED?
E. Seifried, D. Henschler, M. Mueller (German Red Cross Blood Donor Service, Frankfurt am Main, Germany)

14.30 – 14.50
2C-S07-02 CYTOKINE GENE EXPRESSION OF RED BLOOD CELL TRANSFUSION AND MULTIPLE ORGAN FAILURE IN CARDIAC SURGERY PATIENTS
L.S. Sitniakowsky, A.F.L. Later, A. Brand, J.A. Van Hilten (Sanquin Bloodbank, Leiden, The Netherlands)

14.50 – 15.10
2C-S07-03 QUALITY OF LEUCOREDUCED BLOOD COMPONENTS: 6 YEARS OF FOLLOW6UP IN FRANCE
A. Chabanel, S. Bégué, M. Masse (Etablissement Français du Sang, La Plaine Saint Denis, France)

15.10 – 15.30
2C-S07-04 LEUCOFILTRATION OF WHOLE BLOOD PREVENTS THE ACCUMULATION OF PLATELET-DERIVED MICROPARTICLES
H. Ohto, A. Sugawara, K. Yajima, S. Saito, M. Okutsu, K. Kawabata, T. Kanno, K. Nollet (Fukushima Medical University, Fukushima, Japan)

14.00 – 15.30 Napels

Parallel Session S8: Blood Sparing Techniques and Policies
 

14.00 – 14.30
2C-S08-01 GUIDELINES AND POLICIES TO SUPPORT PERI-OPERATIVE CELL SALVAGE
D. Thomas (Swansea NHS Trust, Swansea, United Kingdom)

14.30 – 15.00
2C-S08-02 PHARMACOLOGIC APPROACH TO DECREASING TRANSFUSION
R. Weiskopf (Novonordisk, Tiburon, USA)

15.00 – 15.15
2C-S08-03 EU OPTIMAL BLOOD USE PROJECT
M.A. Hart, E.S. Pirie, E. Arthur, D.B.L. McClelland, I.M. Franklin (Scottish National Blood Transfusion Service, Edinburgh, United Kingdom)

15.15 – 15.30
2C-S08-04 INSTITUTIONAL CHANGE FOLLOWING IMPLEMENTATION OF TRANSFUSION NURSE COORDINATORS IN 25 ONTARIO HOSPITALS: THE ONTRAC PROGRAM
J. Freedman, K. Luke, J.Chiavetta, L.Vernich (St Michael's Hospital, Toronto, Canada)

14.00 – 15.30 Florence

Parallel Session S9: Therapeutic Apheresis and Immune Modulation
 

14.00 – 14.30
2C-S09-01 EXTRACORPORED PHOTOCHOMOTHERAPY-INDUCED INCREASE OF CIRCULATING REGULATORY T-CELLS AS A POSSIBLE MARKER OF EFFICACY IN PATIENTS WITH ACUTE AND CHRONIC GRAFT-VS-HOST DISEASE
P. Perseghin, I. Di Biaso, G. D'Amico, E. Dander, E. Biagi (Ospedale San Gerardo, Monza MI, Italy)

14.30 – 15.00
2C-S09-02 THERAPEUTIC APHERESIS PROCEDURES: MECHANISMS OF ACTION AND IMMUNOMODULATORY EFFECTS
J. Muñoz (Blood Bank, Hospitalet Llobregat, Spain)

15.00 – 15.15
2C-S09-03 THERAPEUTIC PLASMA EXCHANGE EMPLOYING THE NEW SPECTRA OPTIA 1.0 DEVICE. THE ITALIAN EXPERIENCE
C. Perotti, C. Del Fante, G.L. Viarengo, P. Bergamaschi, L. Salvaneschi (Fondazione IRCCS Policlinico S.Matteo, Pavia, Italy)

15.15 – 15.30
2C-S09-04 INFECTION AS THE LEADING CAUSE OF EXACERBATION IN THROMBOTIC THROMBOCYTOPENIC PURPURA EPISODES
C. Arrais, A. Mendrone Júnior, L. Ribeiro Sampaio, N. Hidekazu Tatsui, P. Dorlhiac- Llacer, D. Alencar Fisher Chamone (University of São Paulo, São Paulo, Brazil)

14.00 – 15.35 Sicily

Parallel Session S10: Hepatitis
 

14.00 – 14.25
2C-S10-01 CURRENT PROBLEMS WITH DETECTING AND TRANSMISSION OF HEPATITUS VIRUSES
J.P. Allain (University of Cambridge, Cambridge, United Kingdom)

14.25 – 14.50
2C-S10-02 TRANSFUSION-TRANSMITTED HEPATITIS VERIFIED FROM HEMOVIGILANCE AND LOOKBACK STUDY
M. Satake (Tokyo West Blood Center, Tachikawa, Japan)

14.50 – 15.05
2C-S10-03 ESTIMATING CURRENT INCIDENCE OF HEPATITIS B VIRAL INFECTION AMONG BLOOD DONORS THROUGH A NOVEL APPROACH
S. Zou, S. Stramer, E. Notari, F. Musavi, C. Fang, R. Dodd (American Red Cross, Rockville, MD, USA)

15.05 – 15.20
2C-S10-04 THE NATIONWIDE SURVEY OF IMPLEMENTATION OF PRE- AND POST-TRANSFUSION VIRAL MARKER TESTS IN JAPAN
S. Kino (Asahikawa Medical College Hospital, Asahikawa, Japan)

15.20 – 15.35
2C-S10-05 A FOLLOW UP STUDY ON DETECTION OF HBV DNA POSITIVE AND HBSAG NEGATIVE BLOOD DONORS
X.L. Ye (Shenzhen Blood Center, Shenzhen, China)

15.30 – 16.00 Exhibition Area

COFFEE/TEA BREAK

16.00 – 17.30 Ballroom G - L

Parallel Session S11: Structure and Governance of Blood Transfusion Services
 

16.00 – 16.25
2D-S11-01 STRUCTURE AND GOVERNANCE OF BLOOD TRANSFUSION SERVICES. AMERICAN VIEW: AMERICA'S BLOOD CENTERS (ABC)
C. Bianco (America's Blood Centers, Washington, DC, USA)

16.25 – 16.50
2D-S11-02 ASIAN VIEW : DIFFERENT APPROACHES WITHIN THE ASIA PACIFIC BLOOD NETWORK
R. Hetzel (ARBCS, Melbourne, Australia)

16.50 – 17.15
2D-S11-03 STRUCTURE AND GOVERNANCE OF BLOOD SERVICES: A EUROPEAN VIEW
M. Gorham (European Blood Alliance, Bishops Stortford, United Kingdom)

17.15 – 17.30
2D-S11-04 BLOOD TRANSFUSION COSTS IN NIGERIAN HOSPITALS
F. Ayo, I. Ogbue, G. Ihimekpen, K. Ayankola, A. Olufemi, B. Aiyenigba (National Blood Transfusion Service, Abuja, Nigeria)

16.00 – 17.35 Milan

Parallel Session S12: Cellular Therapies
 

16.00 – 16.25
2D-S12-01 CELL THERAPY
S. Takamoto (Aichi Medical University, Aichi, Japan)

16.25 – 16.50
2D-S12-02 BUILDING AND MANAGING A BIOLOGICAL RESOURCE CENTER
P. Rebulla (Foundation Ospedale Maggiore Policlinico, Milan, Italy)

16.50 – 17.05
2D-S12-03 MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS BY CYCLOPHOSPHAMIDE AND GRANULOCYTE COLONY-STIMULATING FACTOR: FACTORS AFFECTING PROGENITOR CELL YIELDS
A.M. Mendrone, C. Arrais, L. Ribeiro Sampaio, N. Tatsui, D. Alencar Fischer Chamone, F. Luiz Dulley (University of São Paulo, São Paulo, Brazil)

17.05 – 17.20
2D-S12-04 POTENT STEM CELL MOBILIZATION BY AMD3100 INFUSION, AND FUNCTIONAL ANALYSIS OF AMD3100 MOBILIZED CELLS
H. Bonig, T. Papayannopoulou (German Red Cross Blood Center, Frankfurt, Frankfurt am Main, Germany)

17.20 – 17.35
2D-S12-05 HOST NKT CELLS CAN SUPPRESS GVHD AFTER ADOPTIVE TRANSFER IN ALLOGENEIC BMT
J. Yang (Shanghai Blood Center, China, Shanghai, China)

16.00 – 17.35 Napels

Parallel Session S13: Bacterial Contamination of Blood Products
 

16.00 – 16.25
2D-S13-01 REDUCTION OF SEPTIC TRANSFUSION REACTIONS RELATED TO BACTERIA CONTAMINATION WITHOUT IMPLEMENTING BACTERIA DETECTION
G. Andreu, C. Morel (Institut National de la Transfusion Sanguine, Paris, France)

16.25 – 16.50
2D-S13-02 CULTURE SYSTEMS AND THE RESIDUAL RISK OF SEPSIS
R. Benjamin (American Red Cross, Washington, DC, USA)

16.50 – 17.05
2D-S13-03 SENSITIVITY OF THE BACT/ALERT FOR DETECTION OF DIFFERENT BACTERIA SPECIES (PEI BACTERIA STANDARDS) IN DEPENDENCY ON THE INCUBATION TEMPERATURE
U. Schurig, R. Bashir, S. Nicol, J. Brachert, C. Schneider, T. Montag (Paul-Ehrlich Institute, Langen, Germany)

17.05 – 17.20
2D-S13-04 PREVENTING TRANSFUSION-ASSOCIATED BACTERIAL SEPSIS - THE IMPACT OF PLATELET TESTING AT THE SITE OF PRODUCTION
D. Devine, C. Jenkins, B. Atkinson (Canadian Blood Services, Vancouver, Canada)

17.20 – 17.35
2D-S13-05 TWO HEXAPLEX NAT ASSAYS FOR BACTERIAL DETECTION IN PLATELETS
M. Schmidt, S. Falckenberg, M.K. Hourfar, E. Seifried (German Red Cross, Institute Frankfurt, Frankfurt am Main, Germany)

16.00 – 17.35 Florence

Parallel Session S14: Demand and Supply of Blood Products
 

16.00 – 16.25
2D-S14-01 INCREASING EFFICIENCIES IN THE BLOOD SUPPLY CHAIN THROUGH REDUCING HOSPITAL RED CELL WASTAGE
J. Chapman, R. Hick, C. Hyam (Blood Stocks Management Scheme (NHSBT), London, United Kingdom)

16.25 – 16.50
2D-S14-02 FINDING THE RIGHT BALANCE IN BLOOD SUPPLY
D. Teo (Centre for Transfusion Medicine, Singapore, Singapore)

16.50 – 17.05
2D-S14-03 IMPROVED FUNCTION OF PLATELET CONCENTRATES STORED IN A CONTAINER WITH HIGHER OXYGEN PERMEABILITY FOR UP TO 7 DAYS: IN VITRO ANALYSIS USING A PARALLEL PLATE FLOW CHAMBER SYSTEM
S. Miyata, S. Yamamoto, I. Kakutani, T. Sakata, K. Furuta, Y. Tani, H. Shibata, K. Nollet, H. Ohto (National Cardiovascular Center, Suita, Osaka, Japan)

17.05 – 17.20
2D-S14-04 PRELIMINARY STUDY TO INTRODUCE A VENDOR MANAGED INVENTORY SYSTEM IN HOSPITAL STOCK MANAGEMENT
G. Verhoeven, M.M. Klaphaake, A. Tadema, C. Noordzij, L. Oosterom, R. Buining, P. Visscher, I. Ouwehand, C. Hackeng, J. Gorgels, A. Leyte (Sanquin, Amsterdam, The Netherlands)

17.20 – 17.35
2D-S14-05 REASONS AND IMPACTS OF INCREASE OF RED BLOOD CELL SUPPLY IN FRANCE SINCE 2001
S. Hojjat-Assari, G. Gondrexon, T. Bartelmaos, D. Legrand, L. Bardiaux, C. Waller, Ph. Halbout, A. Francois, B. Davis, Th. Schneider, Ph. De Micco (Etablissement Français du Sang, St Denis, France)

16:00 – 17:30 Sicily

Parallel Session S15: Alternatives to Allogeneic Transfusion
 

16.00 – 16.30
2D-S15-01 THE ROLE OF IRON IN ANEMIA MANAGEMENT: COULD INTRAVENOUS IRON CONTRIBUTE TO THE REDUCTION OF BLOOD TRANSFUSIONS?
A. Maniatis (Henry Dunant Hospital, Athens, Greece)

16.30 – 17.00
2D-S15-02 (AUTO) TRANSFUSION IN MAJOR SURGERY, THE SURGEON'S VIEW
A. de Vries (MC Haaglanden, Den Haag, The Netherlands)

17.00 – 17.15
2D-S15-03 USING OF PERFTORAN IN TREATMENT OF ACUTE MASSIVE HAEMORRHAGE
E. Zhibhurt, O. Bonder (Russian Pirogov National Medical Surgical Center, Moscow, Russion Federation)

17.15 – 17.30
DISCUSSION